BIODELIVERY SCIENCES INTERNATIONAL INC 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Jan 28, 2014
Insider Transaction Report
Form 4
Finn Andrew L
Executive Vice President
Transactions
- Exercise/Conversion
Options
2014-01-24−10,603→ 0 totalExercise: $2.05From: 2007-07-27Exp: 2016-07-24→ Common Stock (10,603 underlying) - Exercise/Conversion
Options
2014-01-24−49,000→ 0 totalExercise: $3.03From: 2006-12-01Exp: 2015-12-01→ Common Stock (49,000 underlying) - Exercise/Conversion
Common Stock
2014-01-24$2.05/sh+10,603$21,736→ 786,256 total - Exercise/Conversion
Common Stock
2014-01-24$2.94/sh+8,929$26,251→ 795,185 total - Exercise/Conversion
Common Stock
2014-01-24$3.40/sh+5,147$17,500→ 800,332 total - Exercise/Conversion
Common Stock
2014-01-24$3.03/sh+49,000$148,470→ 849,332 total - Sale
Common Stock
2014-01-24$9.03/sh−143,679$1,297,421→ 705,653 total - Exercise/Conversion
Options
2014-01-24−5,147→ 0 totalExercise: $3.40From: 2005-10-21Exp: 2014-10-21→ Common Stock (5,147 underlying) - Exercise/Conversion
Options
2014-01-24−8,929→ 0 totalExercise: $2.94From: 2006-07-28Exp: 2015-07-28→ Common Stock (8,929 underlying)
Footnotes (2)
- [F1]The sale of the shares of common stock was made pursuant to a 10b5-1 plan.
- [F2]On January 24, 2014, the Reporting Person sold an aggregate of 143,679 shares of the Issuer's Common Stock at a weighted average price of $9.03. The highest sale price for the Common Stock was $9.30 per share and the lowest sale price was $8.67 per share.